Derivados selenados como terapia frente a cáncer, tripanosomas y otras patologías
SECALE
Universidad de Alcalá
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Alcalá (11)
2023
-
Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity
Bioorganic Chemistry, Vol. 138
2021
-
3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice
Acta Tropica, Vol. 215
-
New amides containing selenium as potent leishmanicidal agents targeting trypanothione reductase
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1
-
New phosphoramidates containing selenium as leishmanicidal agents
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 10
2020
-
Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates
Bioorganic and Medicinal Chemistry Letters, Vol. 30, Núm. 17
2019
-
Discovery of new organoselenium compounds as antileishmanial agents
Bioorganic Chemistry, Vol. 86, pp. 339-345
-
Synthesis and leishmanicidal activity of novel urea, thiourea, and selenourea derivatives of diselenides
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5
2016
-
Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 6, pp. 3802-3812
2014
-
Novel hybrid selenosulfonamides as potent antileishmanial agents
European Journal of Medicinal Chemistry, Vol. 74, pp. 116-123
2011
-
Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates
Parasitology Research, Vol. 108, Núm. 1, pp. 233-239
-
Selenocyanates and diselenides: A new class of potent antileishmanial agents
European Journal of Medicinal Chemistry, Vol. 46, Núm. 8, pp. 3315-3323